IPO - EXICURE, INC.

Form Type: S-1

Filing Date: 2025-07-11

Corporate Action: Ipo

Type: New

Accession Number: 000169853025000062

Filing Summary: Exicure, Inc. has filed a Registration Statement under the Securities Act of 1933 for the proposed resale of up to 5,164,595 shares of its common stock by selling stockholders, following private placements completed in 2023 and 2024. This registration is part of the Company’s effort to comply with its obligations under the Registration Rights Agreements. The proposed transaction is critical for Exicure, which is navigating significant operational changes, including past asset sales, and is focused on future growth strategies through acquisitions and partnerships. The document outlines risks related to the company's financial health, including its transition from core research and development activities to strategic alternatives and possible market uncertainties. Exicure intends to leverage its recent acquisitions, such as GPCR USA and its newly formed subsidiary KC Creation, to enhance its long-term value and engage in diverse business avenues including collaborations in biotechnology and renewable energy.